Literature DB >> 9302358

Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.

Y Sun1, F J Ramires, K T Weber.   

Abstract

OBJECTIVE: Myocardial fibrosis, associated with increased expression of angiotensin converting enzyme (ACE) and bradykinin (BK) receptor binding at sites of tissue repair, accompanies chronic elevations in circulating angiotensin II (AngII) and/or aldosterone (ALDO) that simulate chronic cardiac failure. A role for increased ventricular wall stress, associated with arterial hypertension, that can accompany such neurohormonal activation when ventricular function is not compromised, has been held responsible for this structural remodeling. To address this proposition, we monitored morphology of right and left atria and pulmonary artery, where stress is not increased, and compared these structures with hypertensive aorta.
METHODS: Experimental groups included: (1) unoperated and untreated controls; (2) intact rats receiving AngII (9 micrograms/h) for 2 weeks and which causes arterial hypertension; (3) uninephrectomized control rats on a high sodium diet for 6 weeks; and (4) uninephrectomized rats receiving ALDO (0.75 micrograms/h) and a high sodium diet for 6 weeks and which results in gradual onset arterial hypertension. Fibrosis was identified by light microscopy in sections stained with collagen specific picrosirius red, while ACE, AngII and BK receptors binding were localized and quantitated by in vitro autoradiography using 125I-351A, 125I[Sar1,Ile8]AngII, and 125I[Tyr8]BK, respectively. AngII receptor subtype was defined by the presence of excess AT1 (losartan) or AT2 (PD123177) receptor antagonists, respectively.
RESULTS: With either AngII or ALDO administration, and compared to controls, we found: (1) microscopic scarring that replaced lost myocytes in both left and right atria; (2) an increase in adventitial collagen of both pulmonary artery and aorta (perivascular fibrosis); (3) markedly increased ACE binding at fibrous tissue sites in both atria and great vessels; (4) unchanged atrial and great vessel AT1 receptor binding; and (5) significantly increased BK receptor binding at sites of atrial and perivascular fibrosis.
CONCLUSIONS: Thus, the appearance of atrial fibrosis and perivascular fibrosis of aorta and pulmonary artery, together with associated increase in ACE and BK receptor binding, in rats receiving AngII or ALDO suggests these responses are not related to altered ventricular wall stress or arterial hypertension, but rather to these effector hormones of the circulating renin-angiotensin-aldosterone system. Local BK, regulated by ACE found in fibrous tissue and BK receptor binding may play a role in structural remodeling of atria and great vessels in these rat models that stimulate chronic cardiac failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302358     DOI: 10.1016/s0008-6363(97)00097-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  55 in total

Review 1.  Aldosterone and vascular damage.

Authors:  D Duprez; M De Buyzere; E R Rietzschel; D L Clement
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

3.  Chronic atrial ionic remodeling by aldosterone: potentiation of L-type Ca2+ channels and its arrhythmogenic significance.

Authors:  Erick B Ríos-Pérez; Maricela García-Castañeda; Adrián Monsalvo-Villegas; Guillermo Avila
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

4.  Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.

Authors:  Malay S Gandhi; Prajwal A Deshmukh; German Kamalov; Tieqiang Zhao; Wenyuan Zhao; Jonathan T Whaley; Jill R Tichy; Syamal K Bhattacharya; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2008-09       Impact factor: 3.105

Review 5.  Spironolactone in congestive heart failure.

Authors:  J E Soberman; K T Weber
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

6.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Authors:  Yao Sun; Jiakun Zhang; Li Lu; Sue S Chen; Mark T Quinn; Karl T Weber
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

7.  Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation.

Authors:  Uwe Lendeckel; Dobromir Dobrev; Andreas Goette
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

8.  Aldosterone-receptor antagonism and end-stage renal disease.

Authors:  Niall McLaughlin; Todd W B Gehr; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

9.  Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism.

Authors:  German Kamalov; Robert A Ahokas; Wenyuan Zhao; Tieqiang Zhao; Atta U Shahbaz; Patti L Johnson; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-03       Impact factor: 3.105

10.  Relationship between left atrial size and stroke in patients with sinus rhythm and preserved systolic function.

Authors:  Bong Soo Kim; Hyun Jik Lee; Jae Hoon Kim; Hee Sang Jang; Byung Seok Bae; Hyun Jae Kang; Bong Ryeol Lee; Byung Chun Jung
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.